mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma Multiforme
Clinical trial NCT02619864 · COMPLETED
Trial details
- NCT number
- NCT02619864
- Sponsor
- Canadian Cancer Trials Group
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-22
- Primary completion
- 2019-03-22
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.